JCO Highlighted Melanoma Articleshttp://jco.ascopubs.org/American Society of Clinical Oncology (ASCO)http://www.asco.org/images/ascorss.gifJCO Highlighted Melanoma Articleshttp://jco.ascopubs.org/<![CDATA[Phase II, Randomized, Controlled, Double-Blinded Trial of Weekly Elesclomol Plus Paclitaxel Versus Paclitaxel Alone for Stage IV Metastatic Melanoma]]> <![CDATA[National Assessment of Melanoma Care Using Formally Developed Quality Indicators]]> <![CDATA[Serum 25-Hydroxyvitamin D<inf>3</inf> Levels Are Associated With Breslow Thickness at Presentation and Survival From Melanoma]]> <![CDATA[Rotterdam Criteria for Sentinel Node (SN) Tumor Burden and the Accuracy of Ultrasound (US) -Guided Fine-Needle Aspiration Cytology (FNAC): Can US-Guided FNAC Replace SN Staging in Patients With Melanoma?]]> <![CDATA[Serum Amyloid A As a Prognostic Marker in Melanoma Identified by Proteomic Profiling]]> <![CDATA[Phase I/II Trial of Tremelimumab in Patients With Metastatic Melanoma]]> <![CDATA[Phase I/II Study of Ipilimumab for Patients With Metastatic Melanoma]]> <![CDATA[Three Phase II Cytokine Working Group Trials of gp100 (210M) Peptide Plus High-Dose Interleukin-2 in Patients With HLA-A2?Positive Advanced Melanoma]]> <![CDATA[Double-Blind Randomized Phase II Study of the Combination of Sorafenib and Dacarbazine in Patients With Advanced Melanoma: A Report From the 11715 Study Group]]> <![CDATA[Prognostic Factors in Metastatic Rhabdomyosarcomas: Results of a Pooled Analysis From United States and European Cooperative Groups]]>